Total Payments
$177,173
2024 Payments
$17,195
Companies
18
Transactions
354
Medicare Patients
28,117
Medicare Billing
$28.9M
Payment Breakdown by Category
Other$145,839 (82.3%)
Travel$20,455 (11.5%)
Food & Beverage$10,879 (6.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $119,093 | 30 | 67.2% |
| Current or prospective ownership or investment interest | $25,290 | 11 | 14.3% |
| Travel and Lodging | $20,455 | 54 | 11.5% |
| Food and Beverage | $10,879 | 246 | 6.1% |
| Acquisitions | $1,456 | 1 | 0.8% |
| Unspecified | $0 | 12 | 0.0% |
Payments by Type
General
$177,173
342 transactions
Ownership
$0
12 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $86,098 | 99 | $0 (2024) |
| Genentech USA, Inc. | $60,084 | 120 | $0 (2024) |
| US Retina LLC | $26,747 | 24 | $0 (2024) |
| Allergan, Inc. | $1,083 | 52 | $0 (2021) |
| Apellis Pharmaceuticals, Inc. | $730.65 | 12 | $0 (2024) |
| Alimera Sciences, Inc. | $670.84 | 15 | $0 (2024) |
| Alcon Vision LLC | $414.24 | 5 | $0 (2024) |
| Alcon Laboratories Inc | $364.66 | 4 | $0 (2017) |
| ABBVIE INC. | $214.14 | 8 | $0 (2024) |
| EyePoint Pharmaceuticals US, Inc. | $124.32 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17,195 | 45 | Regeneron Healthcare Solutions, Inc. ($16,373) |
| 2023 | $32,620 | 58 | Regeneron Healthcare Solutions, Inc. ($31,661) |
| 2022 | $26,606 | 51 | Regeneron Healthcare Solutions, Inc. ($16,321) |
| 2021 | $19,236 | 38 | US Retina LLC ($10,545) |
| 2020 | $16,260 | 25 | Regeneron Healthcare Solutions, Inc. ($13,048) |
| 2019 | $22,328 | 46 | Genentech USA, Inc. ($17,531) |
| 2018 | $18,345 | 44 | Genentech USA, Inc. ($17,632) |
| 2017 | $24,584 | 47 | Genentech USA, Inc. ($23,583) |
All Payment Transactions
354 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: Immunology and Ophthalmology | ||||||
| 12/18/2024 | Bausch & Lomb Americas Inc. | XIPERE (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Ophthalmology | ||||||
| 12/09/2024 | Dompe US, Inc. | OXERVATE (Drug) | Food and Beverage | In-kind items and services | $75.00 | General |
| Category: SOLUTION/ DROPS | ||||||
| 11/25/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/20/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $77.76 | General |
| Category: EYE CARE | ||||||
| 11/19/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $110.69 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/13/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Ophthalmology | ||||||
| 10/08/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/01/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $95.63 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/21/2024 | Alcon Vision LLC | Constellation (Device) | Food and Beverage | In-kind items and services | $94.53 | General |
| Category: Ophthalmology | ||||||
| 09/20/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $105.78 | General |
| Category: Ophthalmology | ||||||
| 09/18/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $9.01 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/04/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 09/04/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 08/14/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/07/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/24/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Ophthalmology | ||||||
| 07/22/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,566.67 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/09/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: Immunology and Ophthalmology | ||||||
| 06/12/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $4.22 | General |
| Category: Immunology and Ophthalmology | ||||||
| 06/12/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $3.27 | General |
| Category: Immunology and Ophthalmology | ||||||
| 05/29/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 04/17/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $9.19 | General |
| Category: Immunology and Ophthalmology | ||||||
| 04/16/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Travel and Lodging | In-kind items and services | $262.64 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/16/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 5,664 | 40,455 | $23.4M | $5.4M |
| 2022 | 25 | 7,221 | 37,702 | $27.6M | $7.0M |
| 2021 | 25 | 7,563 | 43,687 | $30.6M | $8.2M |
| 2020 | 23 | 7,669 | 44,472 | $30.5M | $8.3M |
Total Patients
28,117
Total Services
166,316
Medicare Billing
$28.9M
Procedure Codes
96
All Medicare Procedures & Services
96 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 378 | 12,786 | $12.8M | $2.3M | 18.1% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 176 | 2,364 | $4.4M | $1.6M | 37.3% |
| 67028 | Injection of drug into eye | Office | 2023 | 714 | 3,843 | $2.9M | $348,999 | 12.2% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 742 | 3,538 | $824,212 | $305,384 | 37.1% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 35 | 9,360 | $879,840 | $271,499 | 30.9% |
| 92134 | Imaging of retina | Office | 2023 | 1,620 | 4,760 | $425,925 | $139,223 | 32.7% |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | Office | 2023 | 47 | 990 | $361,350 | $119,157 | 33.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 828 | 1,132 | $157,756 | $64,622 | 41.0% |
| J3490 | Unclassified drugs | Office | 2023 | 21 | 36 | $194,051 | $62,666 | 32.3% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2023 | 42 | 42 | $127,484 | $36,847 | 28.9% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 101 | 423 | $105,750 | $28,244 | 26.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 261 | 261 | $54,690 | $19,428 | 35.5% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 64 | 242 | $60,500 | $13,689 | 22.6% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 112 | 116 | $29,902 | $10,602 | 35.5% |
| 67036 | Removal of eye fluid (vitreous) between lens and retina | Facility | 2023 | 16 | 16 | $30,610 | $9,178 | 30.0% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2023 | 45 | 52 | $57,775 | $9,102 | 15.8% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 102 | 119 | $19,100 | $7,850 | 41.1% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 78 | 78 | $29,478 | $7,585 | 25.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 49 | 49 | $15,843 | $5,963 | 37.6% |
| 92250 | Photography of the retina | Office | 2023 | 153 | 161 | $23,322 | $4,237 | 18.2% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 43 | 49 | $9,114 | $1,571 | 17.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 23 | 23 | $1,889 | $944.80 | 50.0% |
| J9999 | Not otherwise classified, antineoplastic drugs | Office | 2023 | 14 | 15 | $3,750 | $932.96 | 24.9% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 542 | 16,653 | $16.7M | $3.7M | 22.4% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 217 | 2,718 | $5.0M | $1.9M | 38.7% |
About Dr. John Myers, M.D
Dr. John Myers, M.D is a Ophthalmology healthcare provider based in Pensacola, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1881661585.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Myers, M.D has received a total of $177,173 in payments from pharmaceutical and medical device companies, with $17,195 received in 2024. These payments were reported across 354 transactions from 18 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($119,093).
As a Medicare-enrolled provider, Myers has provided services to 28,117 Medicare beneficiaries, totaling 166,316 services with total Medicare billing of $28.9M. Data is available for 4 years (2020–2023), covering 96 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Retina Specialist, Ophthalmology
- Location Pensacola, FL
- Active Since 03/02/2006
- Last Updated 02/21/2018
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1881661585
Products in Payments
- EYLEA (Biological) $60,486
- Lucentis (Biological) $59,466
- EYLEA HD (Biological) $25,502
- OZURDEX (Drug) $1,014
- Constellation (Device) $659.58
- Syfovre (Drug) $504.58
- Vabysmo (Drug) $449.67
- ILUVIEN (Drug) $268.91
- VABYSMO (Drug) $210.70
- YUTIQ (Drug) $186.70
- Iluvien (Biological) $121.98
- BEOVU (Drug) $119.58
- NGENUITY (Device) $119.32
- EYLEA AFLIBERCEPT INJECTION (Biological) $111.10
- VYZULTA (Drug) $99.97
- Rhopressa (Drug) $97.79
- CIRRUS HD-OCT (Device) $96.64
- Iluvien (Drug) $94.17
- COMBIGAN (Drug) $93.45
- OXERVATE (Drug) $75.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Pensacola
Sunil Gupta, M.d, M.D
Ophthalmology — Payments: $2.4M
Ophthalmology $2.4M
Dr. Jennifer Murray, Md, MD
Ophthalmology — Payments: $12,772
Ophthalmology $12,772
Dr. Timothy Mclaughlin, Md, MD
Ophthalmology — Payments: $9,271
Ophthalmology $9,271
Dr. Richard Livernois, M.d, M.D
Ophthalmology — Payments: $6,727
Ophthalmology $6,727
Dr. Jerry Suelflow, Md, MD
Ophthalmology — Payments: $5,714
Ophthalmology $5,714
Dr. William Aldred, Md, MD
Ophthalmology — Payments: $5,052
Ophthalmology $5,052